<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03935802</url>
  </required_header>
  <id_info>
    <org_study_id>CETC 001</org_study_id>
    <nct_id>NCT03935802</nct_id>
  </id_info>
  <brief_title>Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant Radiotherapy</brief_title>
  <official_title>Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jena</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to investigate the systemic effect of radiotherapy on patients with
      primary non-metastatic breast cancer using CETC and to analyze possible changes in CETC
      quantity under adjuvant radiotherapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In cooperation with the Women's Hospital of the Friedrich Schiller University in Jena, a
      total of 161 patients with clinically proven, primarily non-metastatic breast cancer were
      sampled and examined before and after radiotherapy over a period from 09/2002 to 09/2012. The
      MAINTRAC method was used to quantitatively determine the amount of CETC in the blood and to
      observe its peritherapeutic course.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2002</start_date>
  <completion_date type="Actual">September 1, 2018</completion_date>
  <primary_completion_date type="Actual">September 1, 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>up to 10 years</time_frame>
    <description>from the start of Radiotherapy until death / last seen during follow up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>up to 10 years</time_frame>
    <description>from the start of Radiotherapy until relapse or metastasis / last seen during follow up</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">161</enrollment>
  <condition>Breast Cancer Female</condition>
  <arm_group>
    <arm_group_label>primary non-metastatic breast cancer</arm_group_label>
    <description>primary non-metastatic breast cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation</intervention_name>
    <arm_group_label>primary non-metastatic breast cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary non-metastatic breast cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  histologically confirmed invasive breast carcinoma

          -  age &gt;= 18 years

          -  exclusive treatment at the Jena University Hospital

          -  complete curative-intended adjuvant or definite radiotherapy

          -  at least 2 blood collections (before the start of therapy, after the end of the RT)

        Exclusion Criteria:

          -  presence of metastases

          -  recurrence

          -  DCIS, inflammatory breast cancer

          -  second malignancy &lt;10 years before diagnosis of breast cancer

          -  radiotherapeutic pretreatment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Radiooncology, Jena</name>
      <address>
        <city>Jena</city>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 24, 2019</study_first_submitted>
  <study_first_submitted_qc>May 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2019</study_first_posted>
  <last_update_submitted>May 1, 2019</last_update_submitted>
  <last_update_submitted_qc>May 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jena</investigator_affiliation>
    <investigator_full_name>Matthias Mäurer</investigator_full_name>
    <investigator_title>Dr. Matthias Mäurer</investigator_title>
  </responsible_party>
  <keyword>Radiotherapy</keyword>
  <keyword>CETC</keyword>
  <keyword>CTC</keyword>
  <keyword>breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

